Sales and Marketing

Showing 15 posts of 11524 posts found.

We can work it out

January 13, 2005 Sales and Marketing

Selling pharmaceuticals successfully is really dependent on three factors. You must acquire and demonstrate a high level of disease area …

Global industry commits to new data openness

January 7, 2005 Sales and Marketing

The global pharmaceutical industry has committed to making available all data relating to all marketed products, in a move designed …

UK industry code of practice to be reviewed

January 7, 2005 Sales and Marketing

The ABPI has announced a major review of its self-regulated Code of Practice, seeking the views of stakeholders on the …

Industry contributes to disaster relief in Asia

January 6, 2005 Sales and Marketing AZ, GSK, WHO, disaster, relief, tsunami

Pharmaceutical companies have joined worldwide efforts to bring relief to areas devastated by the tsunami in Asia, donating money and …

Zocor and the high street revolution

January 4, 2005 Sales and Marketing

It’s an exciting time for consumer healthcare divisions in the pharma industry. Two years ago, the Department of Health (DH) …

Yamanouchi to launch prostate cancer drug Eligard

December 30, 2004 Sales and Marketing

A new treatment for advanced prostate cancer, Eligard, has received approval in 24 European countries and will be marketed by …

Avandia advert hypertension claims ‘misleading’

December 30, 2004 Sales and Marketing

Claims that GlaxoSmithKline's diabetes drugs Avandia and Avandamet help to significantly lower blood pressure broke the UK Code of advertising, …

Personalised medicine moves a step closer

December 30, 2004 Research and Development, Sales and Marketing

Doctors will be able to use genetic information to determine the best drug dosage for individual patients following approval of …

Trial data sounds death knell for Iressa

December 21, 2004 Sales and Marketing

AstraZeneca has effectively given up on its cancer drug Iressa, admitting that data from a new large scale trial shows …

FDA recommends alternatives following Celebrex scare

December 21, 2004 Sales and Marketing

A new study linking Celebrex to the same increased risk of heart attacks and strokes as recently withdrawn Vioxx has …

Too close for comfort?

January 19, 2004 Medical Communications, Sales and Marketing doctors, industry reputation

The pharmaceutical industry's increasing scale and influence means that no part of its conduct is above scrutiny, and criticism of …

Get out of the ‘arms race’

December 16, 2003 Sales and Marketing sales, sales force, strategy, technology

As healthcare consumers take more responsibility for their health, analysts predict the dynamic between the traditional pharma sales force, healthcare …

Pfizer hits out at SSRI ruling

December 15, 2003 Sales and Marketing

Pfizer has criticised new UK guidance advising doctors that Prozac is the only SSRI anti-depressant safe to prescribe to children.The …
The Gateway to Local Adoption Series

Latest content